These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32319669)

  • 1. RAD18 promotes colorectal cancer metastasis by activating the epithelial‑mesenchymal transition pathway.
    Li P; He C; Gao A; Yan X; Xia X; Zhou J; Wu J
    Oncol Rep; 2020 Jul; 44(1):213-223. PubMed ID: 32319669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis.
    Jiang S; Li Q; Liu Y; Zhang H; Wang Q; Chen Y; Shi X; Li J; Zhang H; Zhang Y; Xia D; Wu M; Lin J; Zhang C; Pang S; Jiang J; Wen Y; Zhang P
    BMC Cancer; 2021 Feb; 21(1):180. PubMed ID: 33607955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.
    Zhang Y; Feng Y; Ji D; Wang Q; Qian W; Wang S; Zhang Z; Ji B; Zhang C; Sun Y; Fu Z
    Int J Oncol; 2018 Aug; 53(2):620-632. PubMed ID: 29767249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
    Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
    Int J Oncol; 2019 Feb; 54(2):479-490. PubMed ID: 30570110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription.
    Jiang B; Yan B; Yang H; Geng H; Li P
    J Microbiol Biotechnol; 2024 Apr; 34(4):920-929. PubMed ID: 38073330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
    Wang W; Wang H; Xiang L; Ni T; Jin F; Deng J; Zhang Y; Shintaro I; Zhou Y; Liu Y
    Oncol Rep; 2020 Jul; 44(1):77-90. PubMed ID: 32627002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
    Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
    Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway.
    Zou S; Yang J; Guo J; Su Y; He C; Wu J; Yu L; Ding WQ; Zhou J
    Cancer Lett; 2018 Mar; 417():65-74. PubMed ID: 29306013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 17. MEIS2 promotes cell migration and invasion in colorectal cancer.
    Wan Z; Chai R; Yuan H; Chen B; Dong Q; Zheng B; Mou X; Pan W; Tu Y; Yang Q; Tu S; Hu X
    Oncol Rep; 2019 Jul; 42(1):213-223. PubMed ID: 31115559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
    Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
    Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
    Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
    Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
    Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.